Capstone Therapeutics

Capstone Therapeutics

Biotechnology Tempe, Arizona, United States 8 employees
Employees
8
Contacts
3
Emails
3
Phones
2

Capstone Therapeutics Overview

Headquarters
Tempe, Arizona, United States
Phone Number
Available in AeroLeads
Website
capstonethx.com
Industry
Biotechnology
Employees
8
Founded
2008
Company Email
Available in AeroLeads
Keywords
Co

About Capstone Therapeutics

Capstone Therapeutics (OTCQB: CAPS) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. Capstone holds an FDA Orphan drug designation for its lead molecule, AEM-28, for Homozygous Familial Hypercholesterolemia (HoFH) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.

Capstone Therapeutics Contact Details

People in AeroLeads
3
With contact data
3
Email contacts
3
100.0% coverage
Phone contacts
2
66.7% coverage

Capstone Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Joan Matusin Sr. Director Clinical Operations at Capstone Therapeutics
Email
Michael Toporek CEO Soluna Holdings - Managing General Partner at Brookstone Partners
Email Phone
Jock Holliman Executive Chairman and Principal Executive Officer of Capstone Therapeutics
Email Phone

Employees by Management Level

Executive 1 profile
Director 1 profile
Senior / Lead 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 1

Compare Similar Companies to Capstone Therapeutics